• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

易于生成针对淀粉样纤维的类药物构象抗体。

Facile generation of drug-like conformational antibodies specific for amyloid fibrils.

作者信息

Desai Alec A, Zupancic Jennifer M, Trzeciakiewicz Hanna, Gerson Julia E, DuBois Kelly N, Skinner Mary E, Sharkey Lisa M, McArthur Nikki, Ferris Sean P, Bhatt Nemil N, Makowski Emily K, Smith Matthew D, Chen Hongwei, Huang Jie, Jerez Cynthia, Kuo Yun-Huai, Kane Ravi S, Kanaan Nicholas M, Paulson Henry L, Tessier Peter M

机构信息

Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, USA.

Biointerfaces Institute, University of Michigan, Ann Arbor, MI, USA.

出版信息

Nat Chem Biol. 2025 Apr 29. doi: 10.1038/s41589-025-01881-9.

DOI:10.1038/s41589-025-01881-9
PMID:40301692
Abstract

Antibodies that recognize insoluble antigens, such as amyloid fibrils associated with neurodegenerative disorders, are important for research, diagnostic and therapeutic applications. However, these types of antibodies are difficult to generate, typically require animal immunization and also commonly require humanization in the case of therapeutic applications. Here we report a methodology for generating high-quality, fully human, conformation-specific antibodies against amyloid fibrils using a published human nonimmune library, yeast-surface display and quantitative fluorescence-activated cell sorting. Notably, this approach enables the isolation of conformation-specific antibodies against tau fibrils (Alzheimer's disease) and α-synuclein fibrils (Parkinson's disease) with combinations of high affinity, high conformational specificity and, in some cases, low off-target binding that rival or exceed those of clinical-stage antibodies specific for tau (zagotenemab) and α-synuclein (cinpanemab). This approach is expected to simplify the generation of conformation-specific antibodies against diverse protein aggregates and other insoluble antigens.

摘要

识别不溶性抗原(如与神经退行性疾病相关的淀粉样纤维)的抗体对于研究、诊断和治疗应用都很重要。然而,这类抗体难以产生,通常需要动物免疫,而且在治疗应用中通常还需要人源化。在此,我们报告一种使用已发表的人类非免疫文库、酵母表面展示和定量荧光激活细胞分选来生成针对淀粉样纤维的高质量、完全人源、构象特异性抗体的方法。值得注意的是,这种方法能够分离出针对tau纤维(阿尔茨海默病)和α-突触核蛋白纤维(帕金森病)的构象特异性抗体,其具有高亲和力、高构象特异性,在某些情况下还具有低脱靶结合的组合,可与或超过针对tau(扎戈替奈单抗)和α-突触核蛋白(辛帕奈单抗)的临床阶段抗体。预计这种方法将简化针对多种蛋白质聚集体和其他不溶性抗原的构象特异性抗体的产生。

相似文献

1
Facile generation of drug-like conformational antibodies specific for amyloid fibrils.易于生成针对淀粉样纤维的类药物构象抗体。
Nat Chem Biol. 2025 Apr 29. doi: 10.1038/s41589-025-01881-9.
2
Flow cytometric isolation of drug-like conformational antibodies specific for amyloid fibrils.用于淀粉样纤维特异性的类药物构象抗体的流式细胞术分离
bioRxiv. 2023 Jul 4:2023.07.04.547698. doi: 10.1101/2023.07.04.547698.
3
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.α-突触核蛋白反应性抗体作为帕金森病患者血清中的诊断生物标志物。
PLoS One. 2011 Apr 25;6(4):e18513. doi: 10.1371/journal.pone.0018513.
4
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity.具有高构象和序列特异性的抗淀粉样蛋白抗体的理性亲和力成熟。
J Biol Chem. 2021 Jan-Jun;296:100508. doi: 10.1016/j.jbc.2021.100508. Epub 2021 Mar 4.
5
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.新型α-突触核蛋白病理构象特异性单克隆抗体的产生和鉴定。
Neurobiol Dis. 2015 Jul;79:81-99. doi: 10.1016/j.nbd.2015.04.009. Epub 2015 Apr 30.
6
Vaccination with structurally adapted fungal protein fibrils induces immunity to Parkinson's disease.接种结构适配的真菌蛋白原纤维可诱导对帕金森病的免疫。
Brain. 2024 May 3;147(5):1644-1652. doi: 10.1093/brain/awae061.
7
Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.α-突触核蛋白和 Tau 早期异源寡聚化引发协同淀粉样开关。
J Mol Biol. 2018 Aug 3;430(16):2508-2520. doi: 10.1016/j.jmb.2018.04.020. Epub 2018 Apr 25.
8
Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.免疫治疗方法靶向淀粉样蛋白-β、α-突触核蛋白和 Tau,用于治疗神经退行性疾病。
Neurotherapeutics. 2016 Jan;13(1):179-89. doi: 10.1007/s13311-015-0397-z.
9
The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.抗淀粉样β单克隆抗体4G8识别与α-突触核蛋白和胰岛淀粉样多肽淀粉样原纤维相关的通用序列非依赖性表位。
J Alzheimers Dis. 2016;50(2):517-25. doi: 10.3233/JAD-150696.
10
Structural differences of amyloid-β fibrils revealed by antibodies from phage display.噬菌体展示抗体揭示的β-淀粉样蛋白原纤维的结构差异
BMC Biotechnol. 2015 Jun 18;15:57. doi: 10.1186/s12896-015-0146-8.

本文引用的文献

1
Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates.定量流式细胞术选择针对病理性聚集物的 tau 构象纳米抗体。
Front Immunol. 2023 Aug 9;14:1164080. doi: 10.3389/fimmu.2023.1164080. eCollection 2023.
2
Trial of Cinpanemab in Early Parkinson's Disease.西尼潘单抗治疗早期帕金森病的临床试验。
N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395.
3
Isolating Anti-amyloid Antibodies from Yeast-Displayed Libraries.从酵母展示文库中分离抗淀粉样蛋白抗体。
Methods Mol Biol. 2022;2491:471-490. doi: 10.1007/978-1-0716-2285-8_22.
4
Disrupting the Balance of Protein Quality Control Protein UBQLN2 Accelerates Tau Proteinopathy.破坏蛋白质质量控制平衡的 UBQLN2 蛋白加速了 Tau 蛋白病。
J Neurosci. 2022 Mar 2;42(9):1845-1863. doi: 10.1523/JNEUROSCI.1116-21.2021. Epub 2022 Jan 26.
5
Deep learning for Alzheimer's disease: Mapping large-scale histological tau protein for neuroimaging biomarker validation.深度学习在阿尔茨海默病中的应用:为神经影像学生物标志物验证绘制大规模组织学 tau 蛋白图谱。
Neuroimage. 2022 Mar;248:118790. doi: 10.1016/j.neuroimage.2021.118790. Epub 2021 Dec 20.
6
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease.阿杜卡努单抗、扎戈替奈单抗和吡格列酮作为阿尔茨海默病靶向治疗策略的比较分析
Aging Dis. 2021 Dec 1;12(8):1964-1976. doi: 10.14336/AD.2021.0719. eCollection 2021 Dec.
7
Highly sensitive detection of antibody nonspecific interactions using flow cytometry.使用流式细胞术对抗体非特异性相互作用进行高灵敏度检测。
MAbs. 2021 Jan-Dec;13(1):1951426. doi: 10.1080/19420862.2021.1951426.
8
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods.采用新兴的实验和计算方法进行药物样抗体的发现阶段鉴定。
MAbs. 2021 Jan-Dec;13(1):1895540. doi: 10.1080/19420862.2021.1895540.
9
Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties.超稀测量自组装鉴定具有有利高浓度溶液性质的抗体。
Mol Pharm. 2021 Jul 5;18(7):2744-2753. doi: 10.1021/acs.molpharmaceut.1c00280. Epub 2021 Jun 9.
10
Rational affinity maturation of anti-amyloid antibodies with high conformational and sequence specificity.具有高构象和序列特异性的抗淀粉样蛋白抗体的理性亲和力成熟。
J Biol Chem. 2021 Jan-Jun;296:100508. doi: 10.1016/j.jbc.2021.100508. Epub 2021 Mar 4.